Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Therapy-related Thrombocytopenia”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Testing effectiveness (Phase 2)Study completedNCT04478123
What this trial is testing

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Who this might be right for
Multiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 62
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Not applicableNot Yet RecruitingNCT06376435
What this trial is testing

A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced Thrombocytopenia

Who this might be right for
Cancer, Therapy-Related
Hebei Medical University Fourth Hospital 500
Testing effectiveness (Phase 2)UnknownNCT05350956
What this trial is testing

A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia

Who this might be right for
Tumor Therapy-related Thrombocytopenia
The First Affiliated Hospital of Zhengzhou University 60
Not applicableUnknownNCT05160857
What this trial is testing

Clinical Study on the Efficacy and Safety of Hetropapa Ethanolamine Tablets in the Treatment of Thrombocytopenia Caused by Concurrent Radiotherapy and Chemotherapy in Cervical Cancer

Who this might be right for
Tumor Chemotherapy-related Thrombocytopenia
Second Hospital of Shanxi Medical University 30
Not applicableNot Yet RecruitingNCT07198672
What this trial is testing

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

Who this might be right for
HER2-positive Breast Cancer
Zhenzhen Liu 45
Not applicableUnknownNCT05130424
What this trial is testing

A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province

Who this might be right for
Carcinoma;Blood
SuxiaLuo 498
Post-approval studies (Phase 4)Ended earlyNCT04861181
What this trial is testing

NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.

Who this might be right for
Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
Hospices Civils de Lyon 12